MedicineMolecular BiologyOncologyCell SignalingMolecular OncologyTumor ProgressionCancer Cell SignalingCancer ProgressionColorectal CancerSignal Transduction In CancerTumor PromotionTumor Suppressor GenesCancer Signaling PathwaysColorectal Carcinogenesis PathophysiologyEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersPi3k-akt Signaling PathwayPi3k-akt-mtor SignalingReal-time Polymerase Chain Reaction (Pcr)Tumor Growth Dynamics
OBJECTIVE: The dysregulation of deubiquitinating enzymes is important in the development of many cancers, including colorectal cancer (CRC). However, the precise function and potential mode of action of the deubiquitinating enzyme UCHL3 in CRC progression are poorly elucidated. METHODS: . RESULTS: also showed enhanced tumor growth due to UCHL3 overexpression. In addition, UCHL3 was found regulates SOX12 expression in CRC cells. PI3K/AKT/mTOR pathway is required for UCHL3-mediated SOX12 expression. Mechanically, UCHL3 regulates SOX12 via AKT/mTOR signaling pathway and facilitated tumor progression. CONCLUSION: UCHL3 plays an oncogenic role through the AKT/mTOR/SOX12 axis and can be considered as a potential target for therapy and CRC prognostic biomarker.
26
Jingshan Tong, Shuai Tan, Fangdong Zou et al. · Oncogene · 2016 · 169 citations · Full text
Mcl-1 Degradation Is Required for Targeted Therapeutics to Eradicate Colon Cancer Cells
Jingshan Tong, Peng Wang, Shuai Tan et al. · Cancer Research · 2017 · 157 citations · Full text
Medicine, Oncology, Pharmacology +16